BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21182095)

  • 21. [Analysis of antigen-specific proliferation and IL-2/IL-4 production of spleen cells from mice infected with Mycobacterium bovis BCG].
    Teruya K; Kawakami K; Tohyama M; Saito A
    Kekkaku; 1995 Apr; 70(4):293-9. PubMed ID: 7760538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
    Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
    J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycobacterium bovis BCG-infected neutrophils and dendritic cells cooperate to induce specific T cell responses in humans and mice.
    Morel C; Badell E; Abadie V; Robledo M; Setterblad N; Gluckman JC; Gicquel B; Boudaly S; Winter N
    Eur J Immunol; 2008 Feb; 38(2):437-47. PubMed ID: 18203135
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder.
    Lamm DL; Blumenstein BA; Crawford ED; Montie JE; Scardino P; Grossman HB; Stanisic TH; Smith JA; Sullivan J; Sarosdy MF
    N Engl J Med; 1991 Oct; 325(17):1205-9. PubMed ID: 1922207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-17A-producing gammadelta T and Th17 lymphocytes mediate lung inflammation but not fibrosis in experimental silicosis.
    Lo Re S; Dumoutier L; Couillin I; Van Vyve C; Yakoub Y; Uwambayinema F; Marien B; van den Brûle S; Van Snick J; Uyttenhove C; Ryffel B; Renauld JC; Lison D; Huaux F
    J Immunol; 2010 Jun; 184(11):6367-77. PubMed ID: 20421647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer.
    Biot C; Rentsch CA; Gsponer JR; Birkhäuser FD; Jusforgues-Saklani H; Lemaître F; Auriau C; Bachmann A; Bousso P; Demangel C; Peduto L; Thalmann GN; Albert ML
    Sci Transl Med; 2012 Jun; 4(137):137ra72. PubMed ID: 22674550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravesical instillation therapy with bacillus Calmette-Guérin for superficial bladder cancer: study of the mechanism of bacillus Calmette-Guérin immunotherapy.
    Shintani Y; Sawada Y; Inagaki T; Kohjimoto Y; Uekado Y; Shinka T
    Int J Urol; 2007 Feb; 14(2):140-6. PubMed ID: 17302571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early appearing gamma/delta-bearing T cells during infection with Calmétte Guérin bacillus.
    Inoue T; Yoshikai Y; Matsuzaki G; Nomoto K
    J Immunol; 1991 Apr; 146(8):2754-62. PubMed ID: 1707921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of fibronectin-mediated Bacillus Calmette-Guérin attachment to murine bladder mucosa by drugs influencing the coagulation pathways.
    Hudson MA; Brown EJ; Ritchey JK; Ratliff TL
    Cancer Res; 1991 Jul; 51(14):3726-32. PubMed ID: 2065329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder.
    Rosevear HM; Lightfoot AJ; O'Donnell MA; Griffith TS
    Cancer Metastasis Rev; 2009 Dec; 28(3-4):345-53. PubMed ID: 19967427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-infiltrating IL-17-producing gammadelta T cells support the progression of tumor by promoting angiogenesis.
    Wakita D; Sumida K; Iwakura Y; Nishikawa H; Ohkuri T; Chamoto K; Kitamura H; Nishimura T
    Eur J Immunol; 2010 Jul; 40(7):1927-37. PubMed ID: 20397212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gammadelta T-lymphocyte cytotoxic activity against Mycobacterium bovis analyzed by flow cytometry.
    Olin MR; Hwa Choi K; Lee J; Molitor TW
    J Immunol Methods; 2005 Feb; 297(1-2):1-11. PubMed ID: 15777926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell lines.
    Bevers RF; de Boer EC; Kurth KH; Schamhart DH
    Eur Cytokine Netw; 1998 Jun; 9(2):181-6. PubMed ID: 9681394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Editor's choice: Implications of isoniazid resistance in Mycobacterium bovis Bacillus Calmette-Guérin used for immunotherapy in bladder cancer.
    Watts MR; Taylor PC; Sintchenko V; Whelan CM; Farnsworth RH; Jones P; Jelfs P; Carr D; Goldberg H
    Clin Infect Dis; 2011 Jan; 52(1):86-8. PubMed ID: 21148524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of effective antitumor immune responses in a mouse bladder tumor model by using DNA of an alpha antigen from mycobacteria.
    Kuromatsu I; Matsuo K; Takamura S; Kim G; Takebe Y; Kawamura J; Yasutomi Y
    Cancer Gene Ther; 2001 Jul; 8(7):483-90. PubMed ID: 11498769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of IL-12 in the induction and potentiation of IFN-gamma in response to bacillus Calmette-Guérin.
    O'Donnell MA; Luo Y; Chen X; Szilvasi A; Hunter SE; Clinton SK
    J Immunol; 1999 Oct; 163(8):4246-52. PubMed ID: 10510362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant Mycobacterium bovis bacillus Calmette-Guérin expressing Ag85B-IL-7 fusion protein enhances IL-17A-producing innate γδ T cells.
    Hatano S; Tamura T; Umemura M; Matsuzaki G; Ohara N; Yoshikai Y
    Vaccine; 2016 May; 34(22):2490-5. PubMed ID: 27079930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Attachment of bacillus Calmette-Guerin to bladder cancer cells and the expression of interleukin-6 biological activity].
    Zhong H; Gu F; Yu L
    Zhonghua Wai Ke Za Zhi; 1995 Feb; 33(2):119-22. PubMed ID: 7656701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-21 inhibits IL-17A-producing γδ T-cell response after infection with Bacillus Calmette-Guérin via induction of apoptosis.
    Huang Y; Matsumura Y; Hatano S; Noguchi N; Murakami T; Iwakura Y; Sun X; Ohara N; Yoshikai Y
    Innate Immun; 2016 Nov; 22(8):588-597. PubMed ID: 27554052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4+ T-cell activation by antigen-presenting cells infected with urease-deficient recombinant Mycobacterium bovis bacillus Calmette-Guérin.
    Mukai T; Maeda Y; Tamura T; Miyamoto Y; Makino M
    FEMS Immunol Med Microbiol; 2008 Jun; 53(1):96-106. PubMed ID: 18400013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.